Strand Genomics, a life sciences informatics company has expanded its distribution agreement with UBI, Canada for its product Avadis, a tool for data mining, software engineering, micro-array gene expression data analysis.
The Avadis combines scalable analytical algorithms with powerful and interactive visualization to derive valuable insights from the data. The uniqueness of Avadis stems from the depth and versatility of its capabilities in accessing, visualizing and analyzing gene expression data.
The product has the ability to seamlessly access and import data from various sources. It has easy to use wizards to import Affymetrix files including from GCOS. Wizards are also available to support data from spotted arrays. It also provides a wide range of clustering techniques and statistical tests that make up the complete analysis toolset.
As a comprehensive solution, Avadis meets all the needs of gene expression researchers with a superior performance-to-price feature and is available in three editions - Explorer, Prophetic and pride.
According to Lindsay Moir, president, UBI, Avadis is an amazing bargain in terms of power and price for gene expression data mining and analysis. Strand Genomics is putting massive resources behind the success of Avadis and has created a spectacular product."
Avadis improves the efficiency of data analysis many-fold. It empowers a scientist to go from raw data to derived biological insights in a very short time. This is enabled by the core engines of Avadis that are highly scalable, configurable and robust," said Dr. Vijay Chandru, chief executive officer, Strand Genomics.
Strand Genomics is a global life sciences informatics company focused on software for drug discovery and development.